Page last updated: 2024-08-05 12:46:16

4-hydroxy steroid

Any steroid bearing a 4-hydroxy substituent.

ChEBI ID: 62846

Members (8)

MemberDefinitionRole
2,3-dihydro-3beta-methoxy withaferin AA withanolide that is 2,3-dihydrowithaferin A substituted by a beta-methoxy group at position 3. It has been isolated from the aerial parts of Physalis longifolia.2,3-dihydro-3beta-methoxy withaferin A
2,3-dihydro-3beta-O-sulfate withaferin AA withanolide that is 2,3-dihydrowithaferin A substituted by a sulfoxy group at position 3. Isolated from Physalis longifolia, it exhibits antineoplastic activity.2,3-dihydro-3beta-O-sulfate withaferin A
2,3-dihydrowithaferin AA withanolide that is the 2,3-dihydro derivative of withaferin A. It has been isolated from the aerial parts of Physalis longifolia.2,3-dihydrowithaferin A
4-hydroxyestradiolA 4-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 4.4-hydroxy-17beta-estradiol
4-hydroxyestroneA 4-hydroxy steroid that is estrone substituted by a hydroxy group at position 4.4-hydroxyestrone
tubocapsanolide aA withanolide that is 5beta,6beta:16alpha,17alpha-diepoxywitha-2,24-dienolide substituted by a hydroxy group at position 4 and an oxo group at position 1. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.tubocapsanolide A
withaferin aA withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 27 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Physalis longifolia, it exhibits cytotoxic activity.withaferin A
withanolide dA withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 22 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Tubocapsicum anomalum and Withania somnifera, it exhibits cytotoxic activity.withanolide D

Research

Studies (828)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199078 (9.42)18.7374
1990's55 (6.64)18.2507
2000's146 (17.63)29.6817
2010's392 (47.34)24.3611
2020's157 (18.96)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials24 (2.66%)5.53%
Reviews65 (7.21%)6.00%
Case Studies6 (0.67%)4.05%
Observational0 (0.00%)0.25%
Other806 (89.46%)84.16%